Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Thromboangiitis Obliterans (Buerger's Disease).
QJM
November 2024
Department of Rheumatology, Kobe City Medical Center General Hospital, 2-1-1 Minatojima-minami-machi, Chuo-ku, Kobe, Hyogo, 650-0047, Japan.
Factors effecting the success of retrograde tibiopedal access and recanalization in infrapopliteal artery occlusions.
Diagn Interv Radiol
September 2024
Koç University Hospital, Department of Radiology, İstanbul, Türkiye.
Purpose: Peripheral arterial disease (PAD) is increasingly prevalent, particularly among the aging population. Retrograde tibiopedal access (RTPA) has emerged as a useful endovascular treatment for PAD. However, there is limited research examining factors that influence the efficacy of RTPA.
View Article and Find Full Text PDFEffect of Buerger's disease on ocular microvascular structure.
Clin Exp Optom
August 2024
Department of Ophthalmology, Gaziantep Dunya Eye Hospital, Gazianep, Turkey.
Clinical Relevance: Buerger's disease, being a systemic inflammatory vasculopathy, may present with ocular findings.
Background: This study aims to understand the potential role of optical coherence tomography and angiography findings in evaluating the course of Buerger's disease.
Methods: This was a prospective, cross-sectional study that included 25 patients with Buerger's disease (Group 1) and 51 healthy control participants, of whom 27 were smokers (Group 2) and 24 were non-smokers (Group 3).
Gene Therapy of Thromboangiitis Obliterans with Growth Factor Plasmid (VEGF165) and Autologous Bone Marrow Cells.
Biomedicines
July 2024
Clinical Department of Vascular, General and Transplantation Surgery, Wroclaw Medical University, Borowska Street 213, 50-556 Wroclaw, Poland.
Article Synopsis
- A study on gene therapy for critical limb ischemia used VEGF 165 plasmids, with or without stem cells, on 21 patients with thromboangiitis obliterans (TAO).
- Patients were divided into three groups: dual therapy (cells + plasmid), plasmid only, and a control group receiving saline.
- Results showed significant improvements in blood flow and pain reduction in the dual therapy group, indicating that this treatment is safe and effective.
Short-term efficacy of endovascular procedures for lower extremity thromboangiitis obliterans (Buerger's disease).
Postgrad Med
June 2024
Department of General Surgery, Ganzhou People's Hospital, Ganzhou, Jiangxi, People's Republic of China.
Purpose: Although thrombolysis obliterans (TAO) has been recognized for more than a century, there is no optimal treatment for this disease. The aim of this report was to compare the short-term efficacies of catheter-directed thrombolysis (CDT), percutaneous transluminal angioplasty (PTA) and CDT+PTA in treating TAO disease.
Method: Consecutive patients with TAO treated at Ganzhou People's Hospital between 2012 and 2022 were included in this retrospective study.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!